Page last updated: 2024-10-26

dipyridamole and Linear Skull Fracture

dipyridamole has been researched along with Linear Skull Fracture in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Maliha, SG1
Lopez, CD1
Coelho, PG1
Witek, L1
Cox, M1
Meskin, A1
Rusi, S1
Torroni, A1
Cronstein, BN1
Flores, RL1

Other Studies

1 other study available for dipyridamole and Linear Skull Fracture

ArticleYear
Bone Tissue Engineering in the Growing Calvaria Using Dipyridamole-Coated, Three-Dimensionally-Printed Bioceramic Scaffolds: Construct Optimization and Effects on Cranial Suture Patency.
    Plastic and reconstructive surgery, 2020, Volume: 145, Issue:2

    Topics: Animals; Bone Regeneration; Calcium Phosphates; Dipyridamole; Disease Models, Animal; Rabbits; Skull

2020